Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13484062 | 0.94 | ACHE (0.54) | ACHE | |
| SCHEMBL16256698 | 0.94 | ACHE (0.54) | ACHE | |
| Ammonia Solution, Strong SCHEMBL9998894 | 0.93 | ACHE (0.54) | ACHE | |
| SCHEMBL16160556 | 0.93 | ACHE (0.58) | ACHE | |
| SCHEMBL25768077 | 0.92 | ACHE (0.53) | ACHE | |
| SCHEMBL2616673 | 0.92 | ACHE (0.53) | ACHE | |
| SCHEMBL28349559 | 0.92 | ACHE (0.53) | ACHE | |
| SCHEMBL9389713 | 0.92 | ACHE (0.62) | ACHE | |
| SCHEMBL18198077 | 0.92 | ACHE (0.65) | ACHE | |
| SCHEMBL139102 | 0.91 | ACHE (0.48) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2138501-B1 | Functional silane compound, coating solution, and method for manufacturing plastic lens | HOYA CORP (JP) | 2014-08-13 | — | — | EP | disclosed |
| US-8367213-B2 | Biochemical instrument having surface that inhibits nonspecific adsorption | FUJIFILM CORPORATION (JP) | 2013-02-05 | — | — | US | disclosed |
| WO-2012055027-A1 | COATING COMPOSITION COMPRISING SURFACTANT-CONTAINING ORGANOSILICON AND FUNCTIONALIZED SILANE AND METHODS OF MAKING THEREOF | REVISION MILITARY S.A.R.L. (LU) | 2012-05-03 | — | — | WO | disclosed |
| US-7906563-B2 | Polysiloxane-based prepolymer and hydrogel | FAR EASTERN NEW CENTURY CORPORATION (TW) | 2011-03-15 | — | — | US | disclosed |
| US-20100035071-A1 | BIOCHEMICAL INSTRUMENT HAVING SURFACE THAT INHIBITS NONSPECIFIC ADSORPTION | FUJIFILM CORPORATION (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20090311536-A1 | Plastic Lens | HOYA CORPORATION (JP) | 2009-12-17 | — | — | US | disclosed |
| US-20090170976-A1 | Polysiloxane-based prepolymer and hydrogel | FAR EASTERN TEXTILE LTD. | 2009-07-02 | — | — | US | disclosed |
| US-20080300359-A1 | AQUEOUS COATING MATERIAL COMPOSITION | FUJIFILM CORPORATION (JP) | 2008-12-04 | — | — | US | disclosed |
| US-20080097017-A2 | Organic Silicon Compound, Hydrophilic Composition Containing The Same and Hydrophilic Member | FUJIFILM CORPORATION (JP) | 2008-04-24 | — | — | US | disclosed |
| US-20080081184-A1 | BIOCHEMICAL INSTRUMENT | FUJIFILM CORPORATION (JP) | 2008-04-03 | — | — | US | disclosed |
| US-20070232735-A1 | Organic silicon compound, hydophilic composition containing the same and hydrophilic member | FUJIFILM CORPORATION (JP) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232735-A1 | Organic silicon compound, hydophilic composition containing the same and hydrophilic member | H1-3, H1-0, H1-2 | ACHE 3952/4885 |
| US-20080097017-A2 | Organic Silicon Compound, Hydrophilic Composition Containing The Same and Hydrophilic Member | ORC3, OR10J3, H1-3 | ACHE 3732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.